速利清注射液

Ülke: Tayvan

Dil: Çince

Kaynak: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Aktif bileşen:

HISTIDINE;;PROLINE;;LEUCINE;;GLUTAMIC ACID;;CYSTINE;;ALANINE;;THREONINE;;LYSINE;;ARGININE;;ISOLEUCINE;;PHENYLALANINE;;METHIONINE;;VALINE;;SERINE;;GLYCINE (EQ TO AMINOACETIC ACID)(EQ TO GLYCOCOLL);;ASPARTIC ACID;;TYROSINE;;TRYPTOPHAN

Mevcut itibaren:

協立企業股份有限公司 台北巿復興南路１段３４２號１２樓之３ (11336707)

Farmasötik formu:

注射劑

Kompozisyon:

ALANINE (4020100200) 3.00MG; ARGININE (4020100300) 0.25MG; ASPARTIC ACID (4020100400) 3.00MG; CYSTINE (4020100600) 0.01MG; GLUTAMIC ACID (4020100700) 4.50MG; HISTIDINE (4020100900) 1.30MG; ISOLEUCINE (4020101000) 2.00MG; LEUCINE (4020101200) 6.00MG; LYSINE (4020101300) 5.80MG; METHIONINE (4020101500) 0.50MG; PHENYLALANINE (4020101700) 2.00MG; PROLINE (4020101800) 1.60MG; SERINE (4020101900) 0.30MG; THREONINE (4020102000) 0.30MG; TRYPTOPHAN (4020102100) 0.50MG; TYROSINE (4020102200) 0.24MG; VALINE (4020102300) 2.00MG; GLYCINE (EQ TO AMINOACETIC ACID)(EQ TO GLYCOCOLL) (4020102400) 1.50MG

Paketteki üniteler:

安瓿

Sınıf:

製　劑

Reçete türü:

限由醫師使用

Tarafından üretildi:

EBEWE ARZNEIMITTEL GMBH 4866 UNTERACH AM ATTERSEE AT

Terapötik endikasyonlar:

不能攝取適當食物之患者之補助治療劑、蛋白質之消化吸收機能及合成利用障礙、嚴重創傷、火傷、骨折時蛋白質之補給、蛋白質攝取減少之營養失調症

Ürün özeti:

註銷日期: 1988/05/04; 註銷理由: 移轉（申請商）; 有效日期: 1989/07/15; 英文品名: CEREBROLYSIN AMPOULES

Yetkilendirme durumu:

已註銷

Yetkilendirme tarihi:

1983-08-26